Product NDC: | 66582-414 |
Proprietary Name: | Zetia |
Non Proprietary Name: | Ezetimibe |
Active Ingredient(s): | 10 mg/1 & nbsp; Ezetimibe |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66582-414 |
Labeler Name: | Merck Sharp & Dohme Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021445 |
Marketing Category: | NDA |
Start Marketing Date: | 20021025 |
Package NDC: | 66582-414-28 |
Package Description: | 10 BLISTER PACK in 1 CARTON (66582-414-28) > 10 TABLET in 1 BLISTER PACK (66582-414-29) |
NDC Code | 66582-414-28 |
Proprietary Name | Zetia |
Package Description | 10 BLISTER PACK in 1 CARTON (66582-414-28) > 10 TABLET in 1 BLISTER PACK (66582-414-29) |
Product NDC | 66582-414 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ezetimibe |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20021025 |
Marketing Category Name | NDA |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | EZETIMIBE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] |